Results 51 to 60 of about 11,297 (212)

Hemolysis Inhibits Humoral B Cell Responses and Modulates Alloimmunization Risk in Patients with Sickle Cell Disease.

open access: yesBlood, 2020
Red blood cell alloimmunization remains a barrier for safe and effective transfusions in sickle cell disease (SCD), but the associated risk factors remain largely unknown.
M. Pal   +11 more
semanticscholar   +1 more source

Comparison of intrauterine transfusion techniques in hemolytic disease of the fetus and newborn

open access: yesUltrasound in Obstetrics &Gynecology, EarlyView.
ABSTRACT Objectives Intrauterine transfusions (IUTs) are the cornerstone in treatment for hemolytic disease of the fetus and newborn (HDFN). It has been suggested that a non‐vascular intraperitoneal blood transfusion used in conjunction with an intravascular IUT can slow the decrease in fetal hemoglobin (Hb) levels, potentially extending the interval ...
R. M. van 't Oever   +8 more
wiley   +1 more source

Red blood cell alloimmunization in multi-transfused patients with chronic kidney disease in Port Harcourt, South-South Nigeria [PDF]

open access: yes, 2018
Background: Serological safety is an integral part of overall safety for blood banks.Objectives: The aim of the study was to determine the prevalence and specificities of red blood cell alloimmunization in multi-transfused patients  with chronic kidney ...
Obi, Esther Ifeoma   +2 more
core   +2 more sources

The wider perspective: Barriers and recommendations for transfusion support for patients with sickle cell disease in low‐ and middle‐income countries

open access: yesBritish Journal of Haematology, EarlyView.
Globally, sickle cell disease (SCD) is the most common inherited haemoglobinopathy. The highest burden of SCD is encountered in low‐ and middle‐income countries (LMICs), most of which lack the resources to contend with the disease. Blood transfusion remains central to the emergent treatment and prevention of complications of SCD.
Jeremy W. Jacobs   +13 more
wiley   +1 more source

Isohemagglutinins of Graft Origin after ABO-Unmatched Liver Transplantation [PDF]

open access: yes, 1984
THE increasing success of liver transplantation in recent years has provided an experimental model to study and document the hepatic synthesis of many plasma proteins.12345 The normal hepatobiliary tract has not been regarded as a major source of ...
Anderson   +13 more
core   +1 more source

Managing alloimmunization, delayed hemolytic transfusion reactions, and hyper-hemolysis in sickle cell disease [PDF]

open access: yes, 2020
Sickle cell disease (SCD) is an inherited blood disorder in which polymerization of a mutated form of hemoglobin results in a sickled shape of red blood cells, leading to anemia due to premature destruction of RBCs.
Guo, Anqi
core  

Prevalence of red blood cell alloimmunization in multiply transfused patients [PDF]

open access: yes, 2021
Introduction: To analyze the prevalence of alloantibodies in multiply transfused patients. Methods: This study was a retrospective, exploratory and descriptive study with a quantitative approach.
Beninca, Antonio Albuquerque   +4 more
core  

Rh Negative Status and Isoimmunization Update: A Case-Based Approach to Care [PDF]

open access: yes, 2003
Prior to the 1970s and the advent of Rho (D) immune globulin (RIG) for Rh negative women, hemolytic disease of the newborn led to morbidity, long-term disabilities, and mortality.
Hanson, Lisa   +3 more
core   +1 more source

Outcome predictors for maternal red blood cell alloimmunisation with anti-K and anti-D managed with intrauterine blood transfusion [PDF]

open access: yes, 2022
Red blood cell (RBC) alloimmunisation with anti-D and anti-K comprise the majority of cases of fetal haemolytic disease requiring intrauterine red cell transfusion (IUT).
Abbasi, N   +10 more
core   +1 more source

Neonatal Alloimmune Neutropenia [PDF]

open access: yesTransfusion Medicine and Hemotherapy, 2018
Neonatal alloimmune neutropenia (NAIN, NAIN or NIN) is a neutrophil blood group antagonism, analogous to hemolytic disease of the fetus and newborn (HDFN) and fetal/neonatal alloimmune thrombocytopenia (FNAIT). A limited number of prospective screening studies showed that granulocyte-specific antibodies were detectable in 0.35-1.1% of random postnatal ...
Leendert Porcelijn, Masja de Haas
openaire   +2 more sources

Home - About - Disclaimer - Privacy